On the contrary, mouse models lacking major components of innate immunity by either genetic (CCR2-/- mice) or pharmacological manipulation (CSF1R-inhibition) were protected from DEP-induced gut inflammation and glucose intolerance. Here, CCR2 is linked to Glucose intolerance.